DUBLIN--(BUSINESS WIRE)--The "Dry Eye Pipeline Highlights - 2018" report has been added to ResearchAndMarkets.com's offering.
Dry Eye Pipeline Highlights - 2018 provides most up-to-date information on key pipeline products in the global Dry eye market.
It covers emerging therapies for Dry eye in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
SUMMARY:
- Dry eye phase 3 clinical trial pipeline products
- Dry eye phase 2 clinical trial pipeline products
- Dry eye phase 1 clinical trial pipeline products
- Dry eye preclinical research pipeline products
- Dry eye discovery stage pipeline products
- Dry eye pipeline products short-term launch highlights
Clinical Trial Stages:
The report provides Dry eye pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Dry eye pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
Company:
The report provides Dry eye pipeline products by the company.
Short-term Launch Highlights:
Find out which Dry eye pipeline products will be launched in the US and Ex-US till 2020.
For more information about this report visit https://www.researchandmarkets.com/research/26vmtx/dry_eye_pipeline?w=4
